King & Spalding e-Learn: Avoid Product Promotion Landmines – Lessons Learned from 2015 FDA Warning and Untitled Letters and Other Key Developments

Please join us for a review of key takeaways from FDA’s 2015 drug promotion enforcement letters. Learn the issues that were most commonly cited in last year’s FDA Warning and Untitled Letters, as well as other important legal and regulatory developments, and what these mean for your business. Topics to be covered include: (1) FDA enforcement overview, (2) most frequently cited issues, (3) other developments impacting promotion, and (4) best practices to avoid promotion pitfalls.

Program Speakers

• Kelly N. Reeves
• Elaine H. Tseng
• Gillian M. Russell

For more information, contact:

Glenda R. Smith
Senior Paralegal
King & Spalding LLP
1180 Peachtree Street NE
Atlanta, GA 30309
+1 404 572 3017 Direct
glendasmith@kslaw.com

The King & Spalding University e-Learn Series offers monthly one-hour interactive panel presentations. There is no expense to participants.